Tiziana Life Sciences Ltd
TLSA
$1.18
$0.054.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.54% | -77.54% | -21.01% | -21.01% | 20.55% |
| Total Depreciation and Amortization | 135.48% | 135.48% | 41.94% | 41.94% | 51.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.91% | -74.91% | -87.39% | -87.39% | 565.21% |
| Change in Net Operating Assets | 312.79% | 312.79% | -200.71% | -200.71% | -162.01% |
| Cash from Operations | -212.77% | -212.77% | -1,805.75% | -1,805.75% | 55.27% |
| Capital Expenditure | -200.00% | -200.00% | 57.14% | 57.14% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3,360.00% | 3,360.00% | 20,671.43% | 20,671.43% | 99.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -105.56% | -105.56% | 30.43% | 30.43% | 12.20% |
| Issuance of Common Stock | -40.90% | -40.90% | -- | -- | 18,484.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.49% | -41.49% | 10,766.67% | 10,766.67% | 5,697.44% |
| Foreign Exchange rate Adjustments | -966.67% | -966.67% | 129.73% | 129.73% | 101.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.94% | -224.94% | 6,754.72% | 6,754.72% | 147.91% |